SAIPARENT vs VAISHALI: Stock Comparison
Sai Parenterals Ltd is the larger company by market capitalisation. Vaishali Pharma Ltd shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
SAIPARENT leads 3; VAISHALI leads 4 of 8
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | SAIPARENT | VAISHALI |
|---|---|---|
| Sector | — | Healthcare |
| Industry | — | Pharmaceuticals |
Price
| Metric | SAIPARENT | VAISHALI |
|---|---|---|
| Live Price | ₹527.9 | ₹7.97 |
| Day Change | -0.16% | -1.85% |
| Volume | 82,571 | 93,607 |
| 52-Week High | ₹706 | ₹12.75 |
| 52-Week Low | ₹400 | ₹4.75 |
| Distance from 52W High | -25.23% | -37.49% |
Valuation
| Metric | SAIPARENT | VAISHALI |
|---|---|---|
| Market Cap | ₹2,333 Cr | ₹105 Cr |
| P/E Ratio | 163.47x | — |
| P/B Ratio | 4.75x | — |
| EPS | ₹3.23 | ₹0.32 |
| Book Value | — | ₹5.3 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | SAIPARENT | VAISHALI |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 18.35% |
| EPS Growth (TTM YoY) | 0% | -76.71% |
Profitability & Leverage
| Metric | SAIPARENT | VAISHALI |
|---|---|---|
| ROE | 4.88% | 6.02% |
| ROCE | 5.97% | — |
| Net Margin | 3.74% | 3.83% |
| Operating Margin | 10.2% | 3.78% |
| Debt to Equity | 0.68x | 0.27x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | SAIPARENT | VAISHALI |
|---|---|---|
| Promoter Holding | 51.16% | 31.61% |
| FII Holding | 4.03%▼ 1.7 pp | 0% |
| DII Holding | 8.53%▼ 4.33 pp | 0% |
| Public Holding | 36.29%▲ 6.03 pp | 68.39% |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Sai Parenterals Ltd and Vaishali Pharma Ltd.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.